Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05712447 · ClinicalTrials.gov registry record

Duchenne Muscular Dystrophy Video Assessment Registry

A clinical trial of Duchenne Muscular Dystrophy, sponsored by The Emmes Company.

Completed
Registry status
150
Enrollment target
1
Study location

NCT05712447: Completed study of Duchenne Muscular Dystrophy, sponsored by The Emmes Company.

NCT05712447 is a study of Duchenne Muscular Dystrophy that has completed, run by The Emmes Company. The registered enrollment target is 150 participants, below the 409-participant average among 48 other Duchenne Muscular Dystrophy trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05712447, a study of Duchenne Muscular Dystrophy, has completed, sponsored by The Emmes Company.

COMPLETED
Registry status
150 participants
Enrollment target
1
Study location

Study Summary

ARISE is a prospective and longitudinal clinical study of individuals with Duchenne Muscular Dystrophy (DMD) aimed at creating a database of functional motor abilities in this population to support validation efforts of the Duchenne Video Assessment (DVA).

Primary Outcome

The DVA is a home-based clinical outcome assessment that measures ease of movement through identification of compensatory movement patterns. The DVA includes 18 standardized movement tasks that are assigned to participants based on functional subgroup. The DVA directs and trains caregivers to video record patients doing specific movement tasks at home using a secure mobile application. DVA videos are scored by DVA-certified physical therapists using validated scorecards with prespecified compens

Conditions Studied

Duchenne Muscular Dystrophy

Study Locations (1)

Maryland

  • Emmes - Rockville

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2022-09-01
Est. Completion 2026-01-11
The Emmes Company

11 total trials

What the finished NCT05712447 record still lists

NCT05712447 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 409-participant average among 48 other Duchenne Muscular Dystrophy trials with a reported enrollment target (63% lower).

The record links to 1 condition, with Duchenne Muscular Dystrophy appearing as the primary indexed condition, and to 0 interventions.

NCT05712447 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT05712447 about?

NCT05712447 is a clinical study titled "Duchenne Muscular Dystrophy Video Assessment Registry". ARISE is a prospective and longitudinal clinical study of individuals with Duchenne Muscular Dystrophy (DMD) aimed at creating a database of functional motor abilities in this population to support validation efforts of the Duchenne Video Assessment (DVA).

What is the current status of trial NCT05712447?

This trial is currently completed. The enrollment target is 150 participants. The study started on 2022-09-01. Estimated completion is 2026-01-11.

What conditions does trial NCT05712447 study?

This clinical trial studies the following conditions: Duchenne Muscular Dystrophy.

Who is sponsoring clinical trial NCT05712447?

This trial is sponsored by The Emmes Company, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05712447 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Duchenne Muscular Dystrophy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05712447's enrollment target sits among peer trials

150 10th of 48 higher than 39 of 48 other Duchenne Muscular Dystrophy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Duchenne Muscular Dystrophy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT05712447, the US trial registry maintained by the National Library of Medicine. NCT05712447 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.